BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Diagnosis
21 results:

  • 1. Transcriptional Plasticity Drives leukemia Immune Escape.
    Eagle K; Harada T; Kalfon J; Perez MW; Heshmati Y; Ewers J; Koren JV; Dempster JM; Kugener G; Paralkar VR; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
    Blood Cancer Discov; 2022 Sep; 3(5):394-409. PubMed ID: 35709529
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. myb rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
    Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
    Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
    Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
    Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemia.
    Caballero-Palacios MC; Villegas-Ruiz V; Ramírez-Chiquito JC; Medina-Vera I; Zapata-Tarres M; Mojica-Espinosa R; Cárdenas-Cardos R; Paredes-Aguilera R; Rivera-Luna R; Juárez-Méndez S
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):60-67. PubMed ID: 32779388
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nanoformulation of EPZ011989 Attenuates EZH2-c-myb Epigenetic Interaction by Proteasomal Degradation in Acute Myeloid leukemia.
    Kaundal B; Srivastava AK; Dev A; Mohanbhai SJ; Karmakar S; Roy Choudhury S
    Mol Pharm; 2020 Feb; 17(2):604-621. PubMed ID: 31904978
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Knockdown of ZFAS1 suppresses the progression of acute myeloid leukemia by regulating microRNA-150/Sp1 and microRNA-150/myb pathways.
    Gan S; Ma P; Ma J; Wang W; Han H; Chen L; Li X; Wu F; Sun H
    Eur J Pharmacol; 2019 Feb; 844():38-48. PubMed ID: 30502345
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of microRNA and gene networks in human chronic myelogenous leukemia.
    Wang K; Xu Z; Wang N; Tian Y; Sun X; Ma Y
    Mol Med Rep; 2016 Jan; 13(1):453-60. PubMed ID: 26548770
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
    Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
    Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
    Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
    Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines.
    Li SD; Tagami T; Ho YF; Yeang CH
    BMC Syst Biol; 2011 Nov; 5():186. PubMed ID: 22051105
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression patterns of microRNAs associated with CML phases and their disease related targets.
    Machová Poláková K; Lopotová T; Klamová H; Burda P; Trněný M; Stopka T; Moravcová J
    Mol Cancer; 2011 Apr; 10():41. PubMed ID: 21501493
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Fluorescent in situ hybridization with a panel of probes detects molecular cytogenetic abnormalities in patients with chronic lymphocytic leukemia].
    Xu W; Li JY; Li L; Yu H; Shen QD; Fan L; Qiao C; Hong M; Qian SX; Qiu HX
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2537-40. PubMed ID: 19080644
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
    Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Mean level of expression of c-myb gene in leukaemia of children].
    Szmyd K; Chaber R; Fiszer-Maliszewska L; Reich A; Grotthus E; Weclawek-Tompol J; Chybicka A
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):587-93. PubMed ID: 17317889
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. diagnosis of acute basophilic leukemia.
    Duchayne E; Demur C; Rubie H; Robert A; Dastugue N
    Leuk Lymphoma; 1999 Jan; 32(3-4):269-78. PubMed ID: 10037024
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration.
    Beck Z; Bácsi A; Kovács E; Kiss J; Kiss A; Balogh E; Telek B; Tóth FD; Andirkó I; Oláh E; Udvardy M; Rak K
    Leuk Lymphoma; 1998 Jul; 30(3-4):293-306. PubMed ID: 9713961
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [A case report of AML M0:CD7, 33 (+) AML M0 case initially presented with cervical lymphadenopathy].
    Horiguchi J; Yamamura S; Nemoto T; Fujikawa T; Inaba S; Yamazaki Y; Yamada H
    Rinsho Ketsueki; 1992 Apr; 33(4):467-72. PubMed ID: 1602610
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulation of the proto-oncogenes c-sis, c-fos, c-myc and c-myb in acute myeloid leukemias.
    Strassburg CP; Neubauer V; Poliwoda H; Benter T
    Neoplasma; 1992; 39(6):343-7. PubMed ID: 1491723
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.